Center for Movement Disorders, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing, China.
Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Roslindale, MA, United States; Harvard Medical School, Boston, MA, United States.
Parkinsonism Relat Disord. 2023 Oct;115:105860. doi: 10.1016/j.parkreldis.2023.105860. Epub 2023 Sep 19.
Levodopa administration can induce or worsen orthostatic hypotension (OH) in patients with Parkinson's disease (PD). Understanding of acute OH post levodopa (AOHPL) is important for rational drug use in PD patients. Primary objective of this study was to investigate the incidence of AOHPL in PD patients. The secondary objectives were a) hemodynamic character of AOHPL; b) risk factors of AOHPL; c) relationship between motor responsiveness and blood pressure (BP) change.
490 PD inpatients underwent acute levodopa challenge test (LCT). Supine-to-standing test (STS) was done 4 times during LCT, including before levodopa and every hour post levodopa intake within 3 h. Patients were classified into two groups, AOHPL and non-AOHPL. A comprehensive set of clinical features scales was assessed, including both motor (e.g., motor response, wearing-off) and nonmotor symptoms (e.g., autonomic dysfunction, neuropsychology).
33.1% PD patients had OH before drug, 50.8% the same subjects had AOHPL during levodopa effectiveness. PD patients who had better response to levodopa likely to have lower standing mean artery pressure (MAP) and severer systolic BP drop after levodopa intake. BP increased when the motor performance worsened and vice versa. Beneficial response was a risk factors of AOHPL (OR = 1.624, P = 0.017).
AOHPL was very common in PD patients. We suggested that PD patients with risk factors should monitor hemodynamic change during LCT to avoid AOHPL following the introduction or increase of oral levodopa. The fluctuations of BP were complicated and multifactorial, likely caused by the process of PD and levodopa both.
左旋多巴给药可诱发或加重帕金森病(PD)患者的直立性低血压(OH)。了解左旋多巴后急性 OH(AOHPL)对于 PD 患者的合理用药非常重要。本研究的主要目的是调查 PD 患者中 AOHPL 的发生率。次要目标是:a)AOHPL 的血流动力学特征;b)AOHPL 的危险因素;c)运动反应性与血压(BP)变化之间的关系。
490 例 PD 住院患者接受了急性左旋多巴挑战试验(LCT)。LCT 期间共进行了 4 次仰卧位到站立位测试(STS),包括在左旋多巴之前和左旋多巴摄入后 3 小时内每小时一次。将患者分为 AOHPL 组和非 AOHPL 组。评估了一整套临床特征量表,包括运动(例如运动反应、波动)和非运动症状(例如自主神经功能障碍、神经心理学)。
33.1%的 PD 患者在用药前有 OH,50.8%的同一患者在左旋多巴有效期间有 AOHPL。对左旋多巴反应更好的 PD 患者在服用左旋多巴后站立时平均动脉压(MAP)较低,收缩压下降更严重。BP 升高时运动性能恶化,反之亦然。良好的反应是 AOHPL 的危险因素(OR=1.624,P=0.017)。
AOHPL 在 PD 患者中非常常见。我们建议有危险因素的 PD 患者在 LCT 期间监测血流动力学变化,以避免在口服左旋多巴引入或增加后发生 AOHPL。BP 的波动复杂且多因素,可能由 PD 和左旋多巴的过程共同引起。